HEAT BIOLOGICS INC (HTBX) Stock Price & Overview
NYSEARCA:HTBX • US42237K4094
Current stock price
The current stock price of HTBX is 2.38 null. Today HTBX is up by 0.42%. In the past month the price decreased by -22.98%. In the past year, price decreased by -61.92%.
HTBX Key Statistics
- Market Cap
- 61.047M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.41
- Dividend Yield
- N/A
HTBX Stock Performance
HTBX Stock Chart
HTBX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to HTBX. When comparing the yearly performance of all stocks, HTBX is a bad performer in the overall market: 81.8% of all stocks are doing better.
HTBX Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to HTBX. HTBX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
HTBX Earnings
HTBX Forecast & Estimates
10 analysts have analysed HTBX and the average price target is 11.6 null. This implies a price increase of 387.5% is expected in the next year compared to the current price of 2.38.
For the next year, analysts expect an EPS growth of -23.7% and a revenue growth 128.57% for HTBX
HTBX Groups
Sector & Classification
HTBX Financial Highlights
Over the last trailing twelve months HTBX reported a non-GAAP Earnings per Share(EPS) of -1.41. The EPS increased by 9.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -1658.78% | ||
| ROA | -28.99% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
HTBX Ownership
HTBX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.8 | 398.492B | ||
| AMGN | AMGEN INC | 16.04 | 198.265B | ||
| GILD | GILEAD SCIENCES INC | 16.4 | 180.267B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.21 | 121.459B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.95 | 78.932B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.01 | 42.071B | ||
| INSM | INSMED INC | N/A | 30.073B | ||
| BIIB | BIOGEN INC | 11.29 | 27.136B | ||
| NTRA | NATERA INC | N/A | 26.973B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.95 | 23.353B | ||
| MRNA | MODERNA INC | N/A | 21.086B | ||
| EXAS | EXACT SCIENCES CORP | 340.74 | 19.713B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 18.84B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About HTBX
Company Profile
Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in Morrisville, North Carolina and currently employs 49 full-time employees. The company went IPO on 2013-07-24. The Company’s gp96 platform is designed to activate the immune system. This platform has applications in cancer and infectious disease. Its platform leverages gp96’s role as a natural molecular warning system that presents antigens to the immune system. The firm also develops ANTHIM, a treatment for inhalation anthrax. ANTHIM is used in the United States and Canada and sold under the brand name Obiltoxaximab SFL in Europe and the United Kingdom. ANTHIM is a monoclonal antibody that binds to the protective antigen (PA) component of anthrax toxin. ANTHIM’s toxin neutralizing activity prevents entry of anthrax toxin into susceptible cells, avoiding further spread of the toxin throughout the body and the ensuing tissue damage. ANTHIM is supplied as single-dose vials for Intravenous Therapy (IV) infusion. ANTHIM is indicated in adult and pediatric patients.
Company Info
IPO: 2013-07-24
HEAT BIOLOGICS INC
627 Davis Drive, Suite 400
Morrisville NORTH CAROLINA 27560 US
CEO: Jeffrey Wolf
Employees: 49
Phone: 19192407133.0
HEAT BIOLOGICS INC / HTBX FAQ
What does HEAT BIOLOGICS INC do?
Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in Morrisville, North Carolina and currently employs 49 full-time employees. The company went IPO on 2013-07-24. The Company’s gp96 platform is designed to activate the immune system. This platform has applications in cancer and infectious disease. Its platform leverages gp96’s role as a natural molecular warning system that presents antigens to the immune system. The firm also develops ANTHIM, a treatment for inhalation anthrax. ANTHIM is used in the United States and Canada and sold under the brand name Obiltoxaximab SFL in Europe and the United Kingdom. ANTHIM is a monoclonal antibody that binds to the protective antigen (PA) component of anthrax toxin. ANTHIM’s toxin neutralizing activity prevents entry of anthrax toxin into susceptible cells, avoiding further spread of the toxin throughout the body and the ensuing tissue damage. ANTHIM is supplied as single-dose vials for Intravenous Therapy (IV) infusion. ANTHIM is indicated in adult and pediatric patients.
What is the current price of HTBX stock?
The current stock price of HTBX is 2.38 null. The price increased by 0.42% in the last trading session.
Does HEAT BIOLOGICS INC pay dividends?
HTBX does not pay a dividend.
What is the ChartMill rating of HEAT BIOLOGICS INC stock?
HTBX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Where is HEAT BIOLOGICS INC (HTBX) stock traded?
HTBX stock is listed on the NYSE Arca exchange.
Can you provide the market cap for HEAT BIOLOGICS INC?
HEAT BIOLOGICS INC (HTBX) has a market capitalization of 61.05M null. This makes HTBX a Micro Cap stock.